Cargando…
Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy
The devastating global impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has prompted scientists to develop novel strategies to fight Coronavirus Disease of 2019 (COVID-19), including the examination of pre-existing treatments for other viral infections in COVID-19 patients....
Autores principales: | Barros, Inês, Silva, António, de Almeida, Luís Pereira, Miranda, Catarina Oliveira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836230/ https://www.ncbi.nlm.nih.gov/pubmed/33397585 http://dx.doi.org/10.1016/j.cytogfr.2020.12.002 |
Ejemplares similares
-
Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
por: Barros, Inês, et al.
Publicado: (2020) -
Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies
por: Fiore, Esteban Juan, et al.
Publicado: (2018) -
Pleiotropic effects of cancer cells’ secreted factors on human stromal (mesenchymal) stem cells
por: Al-toub, Mashael, et al.
Publicado: (2013) -
Taking advantage of saliva
por: Van Epps, Heather L.
Publicado: (2006) -
Stressin' Sestrins take an aging fight
por: Budanov, Andrei V, et al.
Publicado: (2010)